Clinical Trial Update: Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nimotuzumab in combination with trifluridine/tipiracil for refractory metastatic colorectal cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Refractory Metastatic Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING